Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Decongestant Market Key Developments, Demand & Forecast Report (2024-2032)
Decongestant Market Size Was Valued at USD 15.75 Billion in 2023, and is Projected to Reach USD 28.23 Billion by 2032, Growing at a CAGR of 6.7 % From 2024-2032. Decongestant market includes pharmaceutical products that treat nasal congestion originating from basic allergies, sinusitis, colds, and flu
IMR Group
Description
Decongestant Market Synopsis:
Decongestant Market Size Was Valued at USD 15.75 Billion in 2023, and is Projected to Reach USD 28.23 Billion by 2032, Growing at a CAGR of 6.7 % From 2024-2032.
Decongestant market includes pharmaceutical products that treat nasal congestion originating from basic allergies, sinusitis, colds, and flu. Essential products work by narrowing the blood vessels in the nasal passage hence decreasing on inflammation and the formation of mucus. These products can be in the form of tablets, sprays, drops, and inhalers and others can only be accessed via prescription whereas some are over-the-counter products. Globalization, an increase in the number of cases of respiratory diseases, and increased demand for fast-acting remedies are key factors promoting the growth of this market.
There is a significant increase in the market of decongestants because of the increased incidences of respiratory problems arising from pollution and climatic change. Higher rates of allergic rhinitis, sinusitis is also encouraging people towards consuming these products, as there is always a need for an instant relief from nasal blockage and uneasiness. The use of decongestant nasal sprays along with oral agents has rapidly increased owing to its convenience, easy to use and widely available in the retail shops and online.
In addition, advancements in formulation technology like long-acting decongestant products, multi symptom relief products are favorable forces. High cost of healthcare and customer awareness on How to use decongestant medications particularly on management of nasal congestion without nasty side effects have boasted consumers’ confidence in the products. These trends are accompanied by measures to strengthen the requirements for compliance with regulatory requirements and the correspondence of the quality of produced drugs, which will strengthen the base of the market.
Decongestant Market Trend Analysis:
Shift Toward Natural and Herbal Decongestants
The use of natural and herbal products decongestants is popular with consumer now more than before due to the side effects of synthetic drugs. This trend is characterized by the increase in sales of items that have ingredients such as Menthol, Eucalyptus and Saline. To this, manufacturers have seized the opportunity to launch herbal emissions that suit the environment conscious market. Also, the advancement in the technology sector and digital health raises awareness about respiratory disease and the use of these products, and online pharmacies are now offering these products as additional goods for the respiratory market.
Expansion Through E-commerce Channels
The general increase in the e-marketplace has therefore led to the exposure of several opportunities within the decongestant market. Currently, e-commerce platforms easily provide consumers with easy access to decongestant products, including comparisons between prices and customer feedback. As mobile uptake and internet connection continue to rise, manufacturers are using internet channels to access consumers. Promotional offers, subscription models, and tie-ups with e-pharmacies have added to sales in this segment and have helped the players to explore heretofore untapped customer segments.
Decongestant Market Segment Analysis:
Decongestant Market is Segmented on the basis of product type, application, distribution channel and region.
By Product Type, Tablets segment is expected to dominate the market during the forecast period
The tablets segment is expected to dominate the market throughout shortly because of the mobility, swallowability, and administration. Consumers choose oral decongestant tablets for the purpose of getting quick relief from all types of nasal congestion due to allergies, cold, or flu. These tablets are typically taken alongside antihistamines or pain relievers and are a way of targets multiple symptoms — very appealing. In addition, recent improvements of extended-release and quick-dissolve tablets to improve performance and consumers’ preferences keep propelling demand worldwide.
By Application, Nasal Congestion segment expected to held the largest share
The nasal congestion segment captures the largest market in the decongestant market because sinusitis, allergic rhinitis, and common cold are common ailments. This segment gets value from the increasing use of Over-the-counter Nasal sprays and drops that gives instant relief. Market growth in this segment is further complemented by increased concerns about the management of nasal congestion and the development of new technologies for products with pressurized, sprays and gel systems.
Decongestant Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America is expected to show a high growth rate and dominate in this market by accounting for a third of the global market within the forecast period. High incidences of allergy, sinus, and flu, compounded by changing weather patterns and emissions are dominant in this region hence its strong market leadership. Hu and colleagues report that the United States is one of the key producers, due to the well-developed healthcare system, easy access to OTC drugs, and an increasing number of people concerned with respiratory health.
Also, the growth in leading pharmaceutical firms, strong R&D undertakings, and good policies for the regional market supports the market growth. Referral sales outlets involve retail pharmacies while e-channels involved in the distribution of decongestant products include. Cultural attributes, increased healthcare costs, and demand for natural decongestant solutions boost Canada’s position in the region. It will also persist in the future as they look for ways to improve and strengthen their business operations through designing new products and forming useful connections with other interested consumers.
Active Key Players in the Decongestant Market:
Bayer AG (Germany)
Beximco Pharmaceuticals Ltd. (Bangladesh)
Chattem, Inc. (United States)
Cipla Limited (India)
GlaxoSmithKline plc (United Kingdom)
Johnson & Johnson Services, Inc. (United States)
Merck & Co., Inc. (United States)
Mylan N.V. (United States)
Novartis AG (Switzerland)
Pfizer Inc. (United States)
Prestige Consumer Healthcare Inc. (United States)
Reckitt Benckiser Group PLC (United Kingdom)
Sanofi S.A. (France)
Sun Pharmaceutical Industries Ltd. (India)
Teva Pharmaceutical Industries Ltd. (Israel)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Decongestant Market by Product Type
4.1 Decongestant Market Snapshot and Growth Engine
4.2 Decongestant Market Overview
4.3 Tablets Capsules Nasal Sprays Others
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Tablets Capsules Nasal Sprays Others: Geographic Segmentation Analysis
Chapter 5: Decongestant Market by Application
5.1 Decongestant Market Snapshot and Growth Engine
5.2 Decongestant Market Overview
5.3 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other: Geographic Segmentation Analysis
Chapter 6: Decongestant Market by Distribution Channel
6.1 Decongestant Market Snapshot and Growth Engine
6.2 Decongestant Market Overview
6.3 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super : Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Decongestant Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 BAYER AG (GERMANY)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BEXIMCO PHARMACEUTICALS LTD. (BANGLADESH)
7.4 CHATTEM INC. (UNITED STATES)
7.5 CIPLA LIMITED (INDIA)
7.6 GLAXOSMITHKLINE PLC (UNITED KINGDOM)
7.7 JOHNSON & JOHNSON SERVICES INC. (UNITED STATES)
7.8 MERCK & CO. INC. (UNITED STATES)
7.9 MYLAN N.V. (UNITED STATES)
7.10 NOVARTIS AG (SWITZERLAND)
7.11 PFIZER INC. (UNITED STATES)
7.12 PRESTIGE CONSUMER HEALTHCARE INC. (UNITED STATES)
7.13 RECKITT BENCKISER GROUP PLC (UNITED KINGDOM)
7.14 SANOFI S.A. (FRANCE)
7.15 SUN PHARMACEUTICAL INDUSTRIES LTD. (INDIA)
7.16 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Decongestant Market By Region
8.1 Overview
8.2. North America Decongestant Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product Type
8.2.4.1 Tablets Capsules Nasal Sprays Others
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.2.6 Historic and Forecasted Market Size By Distribution Channel
8.2.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Decongestant Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product Type
8.3.4.1 Tablets Capsules Nasal Sprays Others
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.3.6 Historic and Forecasted Market Size By Distribution Channel
8.3.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Decongestant Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product Type
8.4.4.1 Tablets Capsules Nasal Sprays Others
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.4.6 Historic and Forecasted Market Size By Distribution Channel
8.4.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Decongestant Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product Type
8.5.4.1 Tablets Capsules Nasal Sprays Others
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.5.6 Historic and Forecasted Market Size By Distribution Channel
8.5.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Decongestant Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product Type
8.6.4.1 Tablets Capsules Nasal Sprays Others
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.6.6 Historic and Forecasted Market Size By Distribution Channel
8.6.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Decongestant Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product Type
8.7.4.1 Tablets Capsules Nasal Sprays Others
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold and Flu Other
8.7.6 Historic and Forecasted Market Size By Distribution Channel
8.7.6.1 Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper /Super
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Decongestant Market research report?
A1: The forecast period in the Decongestant Market Research report is 2024-2032.
Q2: Who are the key players in the Decongestant Market?
A2: Bayer AG (Germany), Beximco Pharmaceuticals Ltd. (Bangladesh), Chattem, Inc. (United States), Cipla Limited (India), GlaxoSmithKline plc (United Kingdom), Johnson & Johnson Services, Inc. (United States), Merck & Co., Inc. (United States), Mylan N.V. (United States), Novartis AG (Switzerland), Pfizer Inc. (United States), Prestige Consumer Healthcare Inc. (United States), Reckitt Benckiser Group PLC (United Kingdom), Sanofi S.A. (France), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Other Active Players.
Q3: What are the segments of the Decongestant Market?
A3: The Decongestant Market is segmented into Product Type, Application, Distribution channel, and region. By Product Type, the market is categorized into Tablets Capsules Nasal Sprays Others. By Application, the market is categorized into Seasonal Allergic Rhinitis Perennial Allergic Rhinitis Sinusitis Nasal Congestion Cold, and Flu Others. By Distribution Channel, the market is categorized into Hospital Pharmacies Retail Pharmacies Online Pharmacies Hyper Market/Super Market. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Russia; Bulgaria; The Czech Republic; , Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Q4: What is the Decongestant Market?
A4: The decongestant market includes pharmaceutical products that treat nasal congestion originating from basic allergies, sinusitis, colds, and flu. Essential products work by narrowing the blood vessels in the nasal passage hence decreasing inflammation and the formation of mucus. These products can be in the form of tablets, sprays, drops, and inhalers and others can only be accessed via prescription whereas some are over-the-counter products. Globalization, an increase in the number of cases of respiratory diseases, and increased demand for fast-acting remedies are key factors promoting the growth of this market.
Q5: How big is the Decongestant Market?
A5: Decongestant Market Size Was Valued at USD 15.75 Billion in 2023, and is Projected to Reach USD 28.23 Billion by 2032, Growing at a CAGR of 6.7 % From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
